FIRST YEAR EMBRYOLOGY: PLACENTA


BY MUNEEB HASAN KHAN

 

PLACENTA

DEVELOPMENT:

      Human placenta is an organ of fetomaternal origin and hemochorial type whose development begins in 3rd week, and is well-established by around 4th month.

      Its development involves: 

Maternal Part

Fetal Part

·         In 2nd week, maternal endometrium undergoes decidua reaction and splits into 3 regions:

1.       Parietalis – lines uterine wall apart from conceptus.

2.       Capsularis – superficial part overlying the conceptus.

3.       Basalis–lies deep to conceptus. Basalis forms maternal part of placenta i.e decidual plate.

·         Capsularis enlarges as fetus grows until it contacts Parietalis, and then degenerates. This allows smooth chorion to fuse with decidua parietalis, potentially obliterating the uterine cavity.

·         Amniotic sac enlarges faster than chorionic sac resulting in the fusion of 2 membranes into amniochorionic membrane, with obliteration of chorionic cavity as a result.

·         Early development involves rapid growth of trophoblast engulfing maternal lacunae and development of tertiary chorionic villi. After 8th week, chorionic villi covering the entire chorionic sac undergo 2 gradual changes:

1.       Those at abembryonic pole become compressed by deciduas capsularis and form smooth chorion (laevae).

2.       Those at embryonic pole associated with deciduas basalis grow rapidly to form bushy chorion (frondosum), which serves as fetal part of placenta.

·         Part of chorion related to placenta is chorionic plate.

 

      The 2 parts anchors to each other by cytotrophoblastic shell i.e. external layer of trophoblastic cells on maternal surface of placenta.

      Further on, erosion of endometrium by villi creates 2 effects:

a)      Enlargement of intervillous spaces

b)      Wedge-shaped spokes of deciduas basalis i.e. placental septas that divide the space into incomplete, interconnected compartments (since the septas project towards chorionic plate but do not fuse with it).

      This forms cotyledons in fetal placenta which appear separated by grooves on gross examination. Each cotyledon shows following features:

I.                2 or more Stem villi (extend from chorionic to decidual plates)

II.             Multiple Branch villi (free extensions of stem villi into IV space)

III.          Branches of umbilical vessels supplying the villi (develop from extraembryonic mesoderm)

IV.          Maternal vessels (spiral arteries/endometrial veins) opening into intervillous spaces

(formed by endovascular invasion of cytotrophoblast EVT cells into vessel endothelium)

 

FUNCTIONS OF PLACENTA

1. Metabolism:

·         Synthesis of glycogen, cholesterol, fatty acids etc for nutrition especially during early pregnancy.  

 

2. Transport:

·         Occurs rapidly through large surface area provided by the microvilli of placental membrane.

·         Four major mechanisms: simple diffusion, facilitated diffusion, active transport, pinocytosis.

Transfer of Gases

·         CO2, O2, CO cross rapidly by simple diffusion.

·         Even small disruptions can result in fetal hypoxia &IUGR.

Transfer of Nutrients

·         Water crosses by simple diffusion.

·         Glucose passes by facilitated diffusion through GLUT-1 carrier proteins. o Amino acids cross by active transport.

·         Fats cross in relatively small amounts (esp. long chain polyunsaturated FFA)

·         Vitamins also cross, water-soluble more readily than fat-soluble ones.

Transfer of Maternal Hormones

·         Protein hormones (e.g. insulin) do not cross in significant amounts except thyroid hormones.

·         Unconjugated steroid hormones (e.g. testosterone &progestins) can cross freely.

Transfer of Electrolytes

·          Rapid exchange of electrolytes takes place, each at its own rate, often assisted by facilitated diffusion through channel proteins.

Transfer of Maternal Antibodies/Proteins

·         Small antibodies i.e. IgG (of Rh system) cross placenta and confer passive immunity to fetus.

·         Large antibodies e.g. IgM (of ABO system) cannot cross into fetus.

·         Antibodies against certain diseases in mother can immunize fetus as well e.g. diphtheria, measles & smallpox – and sometimes they do not e.g. pertussis.

·         Other proteins (e.g. transferrin, an iron transport protein) may also pass by transcytosis.

Transfer of Waste Products

·         Urea/Uric acid pass by simple diffusion.

·         Conjugated bilirubin passes rapidly by transport from placenta.

 

Transfer of Drugs

·         Drugs or their metabolites can pass through simple diffusion or active transport, depending on amount circulating in maternal blood.

o   Some drugs act as teratogens. o Consumption of narcotics/alcohol may also affect fetus e.g. fetal addiction and fetal alcohol syndrome.

o   Labour management drugs e.g sedatives, analgesics etc may affect fetus leading to fetal respiratory depression.

Transfer of Infection

·         Infections can pass to fetus through microdefects in the membrane or of their own accord e.g.

  Tryponema pallidum(syphilis) –destructive changes in brain and eyes

  Rubella – cataracts in eye

Ø  Toxoplasma gondii(toxoplasmosis) – mental retardation and eye defects

Ø  Cytomegalovirus, varicella, measles, herpes, poliomyelitis viruses can all cause birth defects in fetus

3. Hormonal synthesis:

·         Protein hormones are:

1.      Human chorionic gonadotropin

2.      Human chorionic somatomammotropin (placental lactogen)

3.      Human chorionic thyrotropin 4. Human chorionic corticotropin

·         Steroid hormones are:

1.      Progesterone

2.      Estrogen

PLACENTA AS ALLOGRAFT

Fetal part of placenta has a genome distinct from mother since half of its chromosomes are paternally inherited; but it does not activate the mother’s immune system. To acquire immunity the fetus must

a.       Evade T cells

b.       Evade NK cells

c.       Protect itself from the complement cascade. These may occur by:

1)      Immunosuppressant molecules – e.g. early pregnancy factor, prostaglandin E2, transforming growth factors (TGF), interleukin 10, indoleamine 2,3-deoxygenase etc.

2)      Lack of MHC complex e.g. on syncytiotrophoblast.

3)      Expression of non-polymorphic HLA-G antigen e.g. on extra villous trophoblastic cells (EVT) that invade spiral artery endothelium, which is not detected by T cells.

4)      Tolerance of maternal B and T cells towards fetus.

5)      Apoptosis of activated maternal leukocytes by receptors on placenta.

6)      Membrane cofactor protein (CD46) which blocks C3 component of complement cascade, preventing its activation.

PLACENTAL MEMBRANE

·         Refers to the structures lining the villi that separate the fetal & maternal circulations from each other.

·         Microdefects can allow non-transferable entities e.g. infectious agents & RBCs to intermingle.

·         Undergoes changes as placenta develops:

o   Until 20th week, consists of 4 layers from periphery to core i.e. syncytiotrophoblast, cytotrophoblast, connective tissue of villus, endothelium of fetal capillaries.

o   After 20th week, it contains 3 layers and starts thinning as a result of:

a)      Disappearance of cytotrophoblastic layer causing only a loose covering of syncytium on villus containing multiple microvilli

b)      Reduction in C.T. of the core

c)      Movement of capillaries towards periphery o All these changes allow a rapid exchange across the membrane. o Multinucleated syncytial knots can form on the syncytium, which may break off and enter maternal circulation. Usually they are destroyed by enzymatic action in maternal lungs. o Hoffbauer cells are also present which are phagocytic.

o   Towards end of pregnancy, many changes occur that cause reduced exchange between the 2 circulations:

a)      Increase in fibrous tissue in core of villus

b)      Thickening of basement membrane in capillaries

c)      Obliteration of small capillaries

d)      Deposition of fibrinoid on surface of villi which reduces exchange.

 


No comments: